Search Tag: personalised oncology

2025 14 Jan

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a significant cause of cancer-related mortality globally. Early-stage HCC offers better treatment prospects compared to advanced cases, yet predicting tumour growth rates remains a major clinical challenge. Tumour volume doubling time (TVDT) can vary significantly among individual...Read more

2024 30 Nov

  Intratumoural heterogeneity is a significant challenge in modern oncology, complicating accurate diagnosis and effective treatment planning. While widely employed, single-site biopsies often fail to capture the full range of genomic, molecular and histological variations within a tumour. As a result, diagnostic accuracy is compromised, and treatment...Read more